Trials / Completed
CompletedNCT00882466
The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction
Phase 4 Study of the Effect of Human Recombinant Erythropoietin at the Time of Reperfusion in Patients With Acute Myocardial Infarction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of intravenous human recombinant erythropoietin on the reperfusion injury at primary percutaneous coronary intervention in patients with acute myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | human recombinant erythropoietin | intravenous bolus injection of EPO (50unit/kg) |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2009-04-16
- Last updated
- 2009-04-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00882466. Inclusion in this directory is not an endorsement.